Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.65 - $1.1 $1,821 - $3,083
-2,803 Reduced 14.99%
15,900 $13,000
Q3 2022

Nov 03, 2022

BUY
$0.79 - $22.0 $2,451 - $68,266
3,103 Added 19.89%
18,703 $16,000
Q2 2021

Aug 04, 2021

SELL
$3.5 - $5.48 $288,120 - $451,113
-82,320 Reduced 84.07%
15,600 $56,000
Q1 2021

Apr 30, 2021

BUY
$3.16 - $4.89 $34,507 - $53,398
10,920 Added 12.55%
97,920 $346,000
Q4 2020

Jan 29, 2021

BUY
$2.2 - $4.45 $52,800 - $106,800
24,000 Added 38.1%
87,000 $276,000
Q3 2020

Nov 05, 2020

BUY
$2.62 - $4.78 $23,580 - $43,020
9,000 Added 16.67%
63,000 $255,000
Q2 2020

Jul 23, 2020

BUY
$1.83 - $3.16 $70,455 - $121,660
38,500 Added 248.39%
54,000 $145,000
Q1 2020

May 05, 2020

BUY
$1.14 - $2.96 $17,670 - $45,880
15,500 New
15,500 $29,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $185M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.